A remark on ‘Bayesian predictive approach to interim monitoring in clinical trials’ by A. Dmitrienko and M-D. Wang

Abstract

Statistics in MedicineVolume 31, Issue 16 p. 1774-1776 Letter to the Editor A remark on ‘Bayesian predictive approach to interim monitoring in clinical trials’ by A. Dmitrienko and M-D. Wang Gengqian Cai, Corresponding Author Gengqian Cai gengqiancai@yahoo.com Quantitative Sciences, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA, 19406 USA Gengqian Cai, Quantitative Sciences, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, USA. E-mail: gengqiancai@yahoo.comSearch for more papers by this authorTianhui Zhou, Tianhui Zhou BioTx Clinical Quantitative Sciences, Pfizer, Collegeville, PA, 19426 USASearch for more papers by this author Gengqian Cai, Corresponding Author Gengqian Cai gengqiancai@yahoo.com Quantitative Sciences, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA, 19406 USA Gengqian Cai, Quantitative Sciences, GlaxoSmithKline, 709 Swedeland Rd., King of Prussia, PA 19406, USA. E-mail: gengqiancai@yahoo.comSearch for more papers by this authorTianhui Zhou, Tianhui Zhou BioTx Clinical Quantitative Sciences, Pfizer, Collegeville, PA, 19426 USASearch for more papers by this author First published: 25 June 2012 https://doi.org/10.1002/sim.4445Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Volume31, Issue1620 July 2012Pages 1774-1776 RelatedInformation